{"id":3996,"date":"2017-08-13T07:38:59","date_gmt":"2017-08-13T07:38:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/andromedic-esho-2014\/"},"modified":"2026-02-17T10:17:41","modified_gmt":"2026-02-17T10:17:41","slug":"andromedic-esho-2014","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/lt\/andromedic-esho-2014\/","title":{"rendered":"Andromedic intervencija ESHO 2014"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/lt\/andromedic-esho-2014\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/lt\/andromedic-esho-2014\/\",\n      \"name\": \"Klinikiniai tyrimai su Andromedic HyDeep 600 WM \u2013 ESHO kongresas\",\n      \"description\": \"HyDeep 600 WM klinikini\u0173 tyrim\u0173 duomenys gimdos kaklelio v\u0117\u017eio gydymui ir daugiacentriai galimybi\u0173 tyrimai, pristatyti ESHO kongrese.\",\n      \"inLanguage\": \"lt-LT\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"about\": [\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"LACC gimdos kaklelio karcinomos tyrimas\",\n          \"description\": \"8 pacient\u0173 tyrimas, rodantis 100 % vietin\u0119 kontrol\u0119 naudojant HyDeep 600 WM sistem\u0105 ir HDR brachiterapij\u0105.\",\n          \"studySubject\": { \"@type\": \"MedicalCondition\", \"name\": \"Gimdos kaklelio v\u0117\u017eys\" }\n        },\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Ispanijos atvejo kontrol\u0117s tyrimas\",\n          \"description\": \"Didelio masto galimybi\u0173 tyrimas su 293 pacientais, apimantis 9 skirtingas navik\u0173 vietas.\",\n          \"sampleSize\": 293,\n          \"studyStatus\": \"Published\"\n        }\n      ],\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Pa\u017eangi onkologin\u0117s hipertermijos sistema \/ profesionalus moduliuoto RF hipertermijos prietaisas (13,56 MHz) vietinei gili\u0105jai hipertermijai.\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/lt\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Kaina pagal u\u017eklaus\u0105\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"Moderniausia giliosios hipertermijos technologija su klini\u0161kai patvirtintais protokolais.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">Europos hipertermin\u0117s onkologijos draugija: ESHO 2014<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">\u201eAndromedic\u201c intervencija \u2013 dr. Salvatore Conte<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\"><a href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO 2014<\/a> kongrese <a href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\"><strong>dr. Salvatore Conte<\/strong><\/a> paskelb\u0117 apie svarb\u0173 \u201eAndromedic\u201c hipertermijos komandos pasiekim\u0105: s\u0117kmingai pagamintus ir pristatytus 25 <a href=\"https:\/\/andromedichyperthermia.com\/lt\/onkologines-hipertermijos-prietaisas\/\"><strong>HyDeep 600WM<\/strong> vietin\u0117s giliosios hipertermijos prietaisus<\/a> vos per 18 m\u0117nesi\u0173, o dar 40 vienet\u0173 numatyta Indijos rinkai.<\/p>\n<\/header>\n<div style=\"margin-bottom: 50px; border-radius: 15px; overflow: hidden; box-shadow: 0 10px 25px rgba(0,0,0,0.2);\">\n<p><iframe loading=\"lazy\" title=\"intervento Andromedic   Esho 20014\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/fgMdXxoJ1cI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<h2 style=\"text-align: center; color: #1a2a6c; margin-bottom: 30px; text-transform: uppercase;\">Pristatyti klinikiniai tyrimai: HyDeep 600WM pa\u017eangi onkologin\u0117 hipertermija<\/h2>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #1a2a6c; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">1. Chemoradioterapija + hipertermija + HDR brachiterapija gydant LACC<\/h3>\n<\/div>\n<div style=\"padding: 30px; background: #f9f9f9;\">\n<p><strong>TIKSLAI:<\/strong> I\u0161tirti kassavaitinio gydymo cisplatinu ir vietin\u0117s giliosios hipertermijos derin\u012f su IMRT, po kurio taikoma brachiterapija (BRT), gydant lokaliai pa\u017eengusi\u0105 gimdos kaklelio karcinom\u0105 (LACC).<\/p>\n<div style=\"background: #fff; padding: 20px; border-radius: 10px; margin: 20px 0; border-left: 5px solid #b21f1f;\">\n<p><strong>MED\u017dIAGOS IR METODAI:<\/strong><\/p>\n<ul style=\"margin-top: 10px; font-size: 15px;\">\n<li><strong>Pacient\u0173 grup\u0117:<\/strong> 8 pacientai (3 \u2013 IIB stadija, 1 \u2013 IIIB, 2 \u2013 NEI, 3 \u2013 LRCC).<\/li>\n<li><strong>Protokolas:<\/strong> 50,4 Gy dubens limfmazgiams su SIB \u012f GTV (i\u0161 viso 61,8 Gy) per 28 frakcijas. BRT doz\u0117: 21 Gy per 3 frakcijas.<\/li>\n<li><strong>Gretutin\u0117 terapija:<\/strong> Kassavaitinis gydymas cisplatinu 40 mg\/m\u00b2 + HT vien\u0105 kart\u0105 per savait\u0119.<\/li>\n<\/ul>\n<\/div>\n<div style=\"background: #e8f5e9; padding: 20px; border-radius: 10px; border: 1px solid #2e7d32;\">\n<p><strong style=\"color: #1b5e20; font-size: 17px; display: block; margin-bottom: 10px;\">REZULTATAI IR I\u0160VADOS:<\/strong><\/p>\n<p style=\"font-size: 16px; font-weight: bold; margin: 0;\">PASIEKTA 100% VIETIN\u0116 KONTROL\u0116. Su gydymu susijusio \u016bmaus ar v\u0117lyvojo 3\u20134 laipsnio toksi\u0161kumo nepasteb\u0117ta.<\/p>\n<p style=\"margin-top: 10px; font-style: italic;\">\u201eVietin\u0117s giliosios hipertermijos prid\u0117jimas prie chemoradioterapijos yra perspektyvi nauja strategija, pasi\u017eyminti puikiu toleravimu.\u201c<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #b21f1f; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">2. Galimybi\u0173 studija (atvejis-kontrol\u0117) \u2013 vietin\u0117 gilioji hipertermija &#8211; Andal\u016bzija, Ispanija<\/h3>\n<\/div>\n<div style=\"padding: 30px;\">\n<p><strong>\u012evadas:<\/strong> Pirmasis klinikinis tyrimas Ispanijoje, derinantis vietin\u0119 gili\u0105j\u0105 hipertermij\u0105 su standartiniais v\u0117\u017eio gydymo metodais vie\u0161ojoje sveikatos prie\u017ei\u016bros sistemoje.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 25px 0;\">\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Tyrimo planas:<\/strong> Prospektyvinis atvejo-kontrol\u0117s tyrimas. I\u0161 viso 293 pacientai (97 aktyviojoje faz\u0117je ir 196 kontrolin\u0117je grup\u0117je). 9 augli\u0173 lokalizacijos.<\/div>\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Gydymo parametrai:<\/strong> 10 seans\u0173 (2\u20133 per savait\u0119), 1 valandos trukm\u0117s, 150W\u2013400W galios, naudojant <strong>\u201eHyDeep 600WM\u201c moduliuotos hipertermijos prietais\u0105<\/strong>.<\/div>\n<\/div>\n<h4 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; display: inline-block; padding-bottom: 5px;\">Preliminar\u016bs duomenys (22 pacient\u0173 pogrupis):<\/h4>\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2;\">\n<li><strong>Glioblastoma (2c)<\/strong><\/li>\n<li><strong>Galvos ir kaklo srities (7c)<\/strong><\/li>\n<li><strong>Prie\u0161operacinis tiesiosios \u017earnos (3c)<\/strong><\/li>\n<li><strong>Kr\u016bties v\u0117\u017eys (3c)<\/strong><\/li>\n<li><strong>Plau\u010di\u0173 (NSCLC &#8211; 11c)<\/strong><\/li>\n<li><strong>Prostatos (4c)<\/strong><\/li>\n<li><strong>Gimdos kaklelio ir metastaz\u0117s<\/strong><\/li>\n<\/ul>\n<div style=\"display: flex; flex-wrap: wrap; gap: 15px; margin: 25px 0;\">\n<div style=\"flex: 1; min-width: 200px; background: #fffde7; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #fbc02d;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">81.2%<\/span><br \/>\n<strong>DIDELIS TOLERAVIMAS<\/strong><br \/>\n<small>Pacientai patenkinti arba labai patenkinti<\/small><\/div>\n<div style=\"flex: 1; min-width: 200px; background: #f1f8e9; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #7cb342;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">66.6%<\/span><br \/>\n<strong>NULINIS TOKSI\u0160KUMAS<\/strong><br \/>\n<small>Nepageidaujam\u0173 rei\u0161kini\u0173 nebuvo<\/small><\/div>\n<\/div>\n<p style=\"background: #f4f7f9; padding: 15px; border-radius: 8px; border-left: 4px solid #1a2a6c;\"><strong>I\u0160VADA:<\/strong> Vietin\u0117 gilioji hipertermija yra \u012fmanoma \u012fprastoje vie\u0161\u0173j\u0173 ligonini\u0173 prie\u017ei\u016broje be papildom\u0173 ypating\u0173 i\u0161tekli\u0173. Tinkama pacient\u0173 atranka u\u017etikrina minimal\u0173 (1 laipsnio) toksi\u0161kum\u0105.<\/p>\n<div style=\"text-align: center; margin-top: 30px;\"><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase; box-shadow: 0 4px 10px rgba(178,31,31,0.3);\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\">Atsisi\u0173sti vis\u0105 tyrimo protokol\u0105 (PDF)<\/a><\/div>\n<\/div>\n<\/section>\n<div style=\"margin-top: 40px;\">\n<h3 style=\"text-align: center; color: #1a2a6c; text-transform: uppercase; letter-spacing: 1px;\">ESHO moksliniai stendiniai prane\u0161imai ir dokumentacija<\/h3>\n<div id='gallery-1' class='gallery galleryid-3996 gallery-columns-1 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/lt\/preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"590\" height=\"837\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1335\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1335'>\n\t\t\t\tPreliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/lt\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-b-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"569\" height=\"831\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1314\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg 569w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B-205x300.jpg 205w\" sizes=\"auto, (max-width: 569px) 100vw, 569px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1314'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/lt\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"826\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1293\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg 568w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-206x300.jpg 206w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1293'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Europos hipertermin\u0117s onkologijos draugija: ESHO 2014 \u201eAndromedic\u201c intervencija \u2013 dr. Salvatore Conte ESHO 2014 kongrese dr. Salvatore Conte paskelb\u0117 apie svarb\u0173 \u201eAndromedic\u201c hipertermijos komandos pasiekim\u0105: s\u0117kmingai pagamintus ir pristatytus 25 HyDeep 600WM vietin\u0117s giliosios hipertermijos prietaisus vos per 18 m\u0117nesi\u0173, o dar 40 vienet\u0173 numatyta Indijos rinkai. Pristatyti klinikiniai tyrimai: HyDeep 600WM pa\u017eangi onkologin\u0117 hipertermija&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17347,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-3996","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/pages\/3996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/comments?post=3996"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/pages\/3996\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/media\/17347"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/media?parent=3996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}